Red biotechnology Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, UK, Germany, China - Size and Forecast 2024-2028

Published: Dec 2023

Pages: 166

SKU: IRTNTR76970

Snapshot

Red Biotechnology Market Forecast 2024-2028

The global red biotechnology market size is estimated to grow by USD 174.56 billion at a CAGR of 6.23% between 2023 and 2028. The market faces challenges such as high development costs and emerging intellectual property issues for vendors, complicating the development and scaling of biotechnology products. However, market growth is propelled by factors like advancements in genomic research, the rising prevalence of chronic diseases, and the increasing global aging population.

In the realm of the market, genomic research emerges as a pivotal driver, catalyzing remarkable advancements in medical applications and healthcare. The escalating importance of genetics has spurred a surge in innovation and development within this sector. The decoding of the human genome marks a significant milestone in scientific history, propelling relentless progress in genomics. This has paved the way for transformative breakthroughs in personalized medicine, diagnostics, and therapeutic interventions. Notably, the emergence of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) gene editing technology stands as a testament to the revolutionary strides in genetic engineering.

Moreover, the convergence of advanced technologies and scientific expertise has fueled an era of unprecedented growth and innovation in the market. The development of novel biopharmaceuticals, gene-based therapies, and stem cell treatments exemplifies the transformative impact of modern technology in healthcare solutions. This synergy has accelerated the translation of cutting-edge research into tangible medical innovations, ranging from diagnostic instruments to medicinal medications and medical devices.

It also includes an in-depth analysis of drivers, trends, and challenges. Besides analyzing the current market scenario, our report examines historical data from 2018-2022.

What will be the Size of the Red biotechnology Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation

Technavio has segmented the market into Product, End-user, and Geography

The product segment includes monoclonal antibodies, gene therapy, polyclonal antibodies, cell-based immunotherapy products, and others
The end-user segment includes pharmaceutical and biotechnology companies, CMOsand CROs, and academic research institutes
The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

Product Analysis

Monoclonal antibodies

The market share growth by the monoclonal antibodies segment will be significant during the forecast period. Monoclonal antibodies play a crucial role in the global red biotechnology market and are recognized as a major market segment in the red biotechnological product landscape. Monoclonal antibody R&D has seen tremendous growth in recent years. This is due to several factors, such as an increase in chronic diseases, advances in biotechnology, and the growing need for personalized medicine.

Get a glance at the market contribution of various segments Download PDF Sample

The monoclonal antibodies segment was valued at USD 161.64 billion in 2018. Monoclonal antibodies represent a unique and important segment that has made substantial contributions to the progress of therapeutic and diagnostic applications. Because of their capacity for tailored therapy, monoclonal antibodies play a significant role in the medical and pharmaceutical applications that are the focus. Furthermore, artificially made molecules called monoclonal antibodies are intended to replicate the immune system's defense against dangerous invaders. Thus, such features and properties of the monoclonal antibodies segment will expand the growth of the global market during the forecast period.

End-user Analysis

Pharmaceutical and biotechnology companies

Pharmaceutical firms are primarily involved in the research, development, production, and distribution of biologically derived medications for illness diagnosis, treatment, and prevention. Red biotechnology uses techniques such as genetic engineering, recombinant DNA technology, and cell culture to produce biological medications, such as vaccinations, antibodies, and gene treatments. Besides, many market players, such as AstraZeneca Plc, Pfizer Inc., Amgen Inc., F. Hoffmann La Roche Ltd., and Teva Pharmaceutical Industries Ltd., are carrying out scientific innovations, R&D, and processes in red biotechnology. Thus, such factors will drive the growth of the segment of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America emerges as a significant participant in the global market since it is home to eminent businesses and academic institutions that are at the forefront of advances. Moreover, the numerous significant red biotech businesses are based in the US, which is a major contributor to the North American biotech market. Canada is another important participant in the regional market. The market in North America also highlights the cooperation between research institutions and industry participants. Hence, such factors are expected to drive market growth in this region during the forecast period.

Buy Full Report Now

Key Red biotechnology Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Amgen Inc.: The company offers red biotechnology solutions such as ACTIMMUNE, Aimovig, Aranesp, and others.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The market is witnessing robust growth due to several key drivers and emerging trends. With advancements in diagnostics, gene therapy, and therapeutic technology, there's a significant focus on developing innovative solutions for addressing diseases like cancer and rare genetic disorders. Clinical research and trials play a pivotal role in validating new therapies, and driving collaboration between academia, healthcare industry players, and biopharmaceutical companies like Novartis. The emergence of personalized medicine, leveraging genetic factors and stem cells, is revolutionizing treatment paradigms, allowing for tailored interventions that target individual patient needs. Moreover, the continuous evolution of modern technology and genetic engineering techniques is accelerating the development and manufacturing of novel drugs, vaccines, and medical devices, further propelling the growth of the pharmaceutical and biotechnology industries.

Furthermore, the increasing demand for healthcare solutions and medical innovations is fostering a dynamic landscape in medical biotechnology. This includes the development of advanced diagnostic instruments to better understand genetic and cellular processes underlying diseases. With a strong emphasis on precision medicine and personalized healthcare, there's a shift towards targeted therapies that offer enhanced efficacy and fewer side effects. This trend is driving investments in research and development across various therapeutic areas, with a focus on translating scientific discoveries into practical applications for patients. Overall, the red biotechnology market is poised for continued expansion as it addresses unmet medical needs and harnesses the potential of cutting-edge technologies to improve patient outcomes and quality of life.

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key trends, and challenges.

Significant Market Trends

Rising stem cell research and therapies are the primary trends shaping market growth. The hopeful developments in stem cell research have led to a boom in interest and investments in the sector, which is mostly focused on medical applications. Moreover, because of their extraordinary capacity to differentiate into distinct cell types, stem cells are a very useful tool in the field of regenerative medicine. There is a noticeable rise in the number of businesses and research centers in the worldwide industry that are committed to using stem cells for medicinal applications.

Furthermore, the effectiveness of mesenchymal stem cell (MSC) therapies in the treatment of orthopedic diseases is one notable example. Significant progress has been achieved in the development of MSC-based therapies for ailments including osteoarthritis and back pain by market players like Mesoblast. Hence, such advances will fuel the growth of the global market during the forecast period.

Major Market Challenges

High development costs is a challenge that affects market growth. Red biotechnology, sometimes known as medical biotechnology, is centered on the creation of medications, medicines, and diagnostic tools for use in healthcare. Research and development in this industry is complicated and resource-intensive, which has led to rising expenses and created a significant barrier for both established businesses and up-and-coming firms.

Moreover, the strict regulatory environment in the global market is one of the main causes of the high development expenses. To assure the safety and efficacy of novel biotechnological products, stringent regulatory standards imposed by global health authorities, like the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA), require comprehensive preclinical and clinical testing. Thus, such factors will impede the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest trends and growth opportunities from 2018 to 2028.

Product Outlook
- Monoclonal antibodies
- Gene therapy
- Polyclonal antibodies
- Cell-based immunotherapy products
- Others

End-user Outlook
- Pharmaceutical and biotechnology companies
- CMOs and CROs
- Academic research institutes

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World (ROW)
  - Brazil
  - Argentina
  - Australia
  - Rest of the World

Market Analyst Overview

Red biotechnology, focused on medical and pharmaceutical applications, drives innovation in healthcare, especially in areas like cancer, rare diseases, and genetic disorders. Breakthroughs in gene-based therapies, such as CAR-T cell therapy for diseases like follicular lymphoma and multiple myeloma, highlight its impact. With a growing geriatric population and the prevalence of chronic illnesses, personalized healthcare solutions utilizing genetic factors and precision medicine are gaining prominence. Biopharmaceuticals, gene therapy products, and diagnostic instruments are at the forefront of this revolution, leveraging genetic engineering methods and recombinant DNA technologies. Stem cell therapy, tissue engineering, and CRISPR gene-editing technology further advance the field, offering hope for conditions like sickle cell anemia and cystic fibrosis. Red biotechnology is thus reshaping healthcare by tailoring treatments to individual genetic susceptibilities, leading to personalized precision medicine and transformative medical innovations in areas like regenerative medicine and disability management.

Furthermore, it is a cornerstone of the healthcare industry, spearheads innovation in therapeutic technology and pharmaceuticals. Focused on developing new drugs, vaccines, and advanced medical devices, it harnesses modern technology to address genetic and cellular processes underlying diseases. With a growing aging population and rising prevalence of inherited illnesses, red biotech pioneers tailored medicine approaches and cutting-edge cancer therapies targeting mutations. Moreover, advancements in regeneration, including gene and cell therapies, hold promise for treating age-related conditions like kidney and knee joint ailments. Backed by subject-related expert advice and revolutionary bioprinting techniques, red biotechnology continues to redefine healthcare, offering personalized solutions to combat the aging process and enhance the quality of life.

Red biotechnology Market Scope
Report Coverage	Details
Page number	166
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 6.23%
Market Growth 2024-2028	USD 174.56 billion
Market structure	Fragmented
YoY growth 2023-2024(%)	5.77
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 38%
Key countries	US, Canada, UK, Germany, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Bayer AG, Biogen Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Bruker Corp., CRISPR Therapeutics AG, Editas Medicine Inc., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., Merck KGaA, Mesoblast Ltd., Moderna Inc., Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., STEMCELL Technologies Inc., and Teva Pharmaceutical Industries Ltd.
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
Precise estimation of the size of the market size and its contribution to the parent market
Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
Comprehensive market analysis and report on the factors that will challenge the market research and growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global red biotechnology market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global red biotechnology market 2018 - 2022 ($ billion)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ billion)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ billion)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ billion)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Monoclonal antibodies - Market size and forecast 2023-2028
- Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)

6.4 Gene therapy - Market size and forecast 2023-2028
- Exhibit 38: Chart on Gene therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 39: Data Table on Gene therapy - Market size and forecast 2023-2028 ($ billion)
- Exhibit 40: Chart on Gene therapy - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Gene therapy - Year-over-year growth 2023-2028 (%)

6.5 Polyclonal antibodies - Market size and forecast 2023-2028
- Exhibit 42: Chart on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 43: Data Table on Polyclonal antibodies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 44: Chart on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Polyclonal antibodies - Year-over-year growth 2023-2028 (%)

6.6 Cell-based immunotherapy products - Market size and forecast 2023-2028
- Exhibit 46: Chart on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
- Exhibit 47: Data Table on Cell-based immunotherapy products - Market size and forecast 2023-2028 ($ billion)
- Exhibit 48: Chart on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Cell-based immunotherapy products - Year-over-year growth 2023-2028 (%)

6.7 Others - Market size and forecast 2023-2028
- Exhibit 50: Chart on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 51: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
- Exhibit 52: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 53: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.8 Market opportunity by Product
- Exhibit 54: Market opportunity by Product ($ billion)
- Exhibit 55: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 56: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 57: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 58: Chart on Comparison by End-user
- Exhibit 59: Data Table on Comparison by End-user

7.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
- Exhibit 60: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 61: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
- Exhibit 62: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)

7.4 CMOs and CROs - Market size and forecast 2023-2028
- Exhibit 64: Chart on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
- Exhibit 65: Data Table on CMOs and CROs - Market size and forecast 2023-2028 ($ billion)
- Exhibit 66: Chart on CMOs and CROs - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on CMOs and CROs - Year-over-year growth 2023-2028 (%)

7.5 Academic research institutes - Market size and forecast 2023-2028
- Exhibit 68: Chart on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 69: Data Table on Academic research institutes - Market size and forecast 2023-2028 ($ billion)
- Exhibit 70: Chart on Academic research institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 71: Data Table on Academic research institutes - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 72: Market opportunity by End-user ($ billion)
- Exhibit 73: Data Table on Market opportunity by End-user ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 74: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 75: Chart on Market share by geography 2023-2028 (%)
- Exhibit 76: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 77: Chart on Geographic comparison
- Exhibit 78: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 79: Chart on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 80: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
- Exhibit 81: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 83: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 84: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
- Exhibit 85: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 87: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 88: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
- Exhibit 89: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 91: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 92: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
- Exhibit 93: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 95: Chart on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 96: Data Table on US - Market size and forecast 2023-2028 ($ billion)
- Exhibit 97: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 China - Market size and forecast 2023-2028
- Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
- Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 103: Chart on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 104: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
- Exhibit 105: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Canada - Market size and forecast 2023-2028
- Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
- Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%)

9.11 Germany - Market size and forecast 2023-2028
- Exhibit 111: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 112: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
- Exhibit 113: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 114: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 115: Market opportunity by geography ($ billion)
- Exhibit 116: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 117: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 118: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 119: Overview on factors of disruption

11.4 Industry risks
- Exhibit 120: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 121: Vendors covered

12.2 Market positioning of vendors
- Exhibit 122: Matrix on vendor position and classification

12.3 Amgen Inc.
- Exhibit 123: Amgen Inc. - Overview
- Exhibit 124: Amgen Inc. - Product / Service
- Exhibit 125: Amgen Inc. - Key offerings

12.4 Astellas Pharma Inc.
- Exhibit 126: Astellas Pharma Inc. - Overview
- Exhibit 127: Astellas Pharma Inc. - Product / Service
- Exhibit 128: Astellas Pharma Inc. - Key news
- Exhibit 129: Astellas Pharma Inc. - Key offerings

12.5 AstraZeneca Plc
- Exhibit 130: AstraZeneca Plc - Overview
- Exhibit 131: AstraZeneca Plc - Product / Service
- Exhibit 132: AstraZeneca Plc - Key news
- Exhibit 133: AstraZeneca Plc - Key offerings

12.6 Bayer AG
- Exhibit 134: Bayer AG - Overview
- Exhibit 135: Bayer AG - Business segments
- Exhibit 136: Bayer AG - Key news
- Exhibit 137: Bayer AG - Key offerings
- Exhibit 138: Bayer AG - Segment focus

12.7 Biogen Inc.
- Exhibit 139: Biogen Inc. - Overview
- Exhibit 140: Biogen Inc. - Product / Service
- Exhibit 141: Biogen Inc. - Key offerings

12.8 Boehringer Ingelheim International GmbH
- Exhibit 142: Boehringer Ingelheim International GmbH - Overview
- Exhibit 143: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 144: Boehringer Ingelheim International GmbH - Key news
- Exhibit 145: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 146: Boehringer Ingelheim International GmbH - Segment focus

12.9 Bristol Myers Squibb Co.
- Exhibit 147: Bristol Myers Squibb Co. - Overview
- Exhibit 148: Bristol Myers Squibb Co. - Product / Service
- Exhibit 149: Bristol Myers Squibb Co. - Key news
- Exhibit 150: Bristol Myers Squibb Co. - Key offerings

12.10 Bruker Corp.
- Exhibit 151: Bruker Corp. - Overview
- Exhibit 152: Bruker Corp. - Business segments
- Exhibit 153: Bruker Corp. - Key news
- Exhibit 154: Bruker Corp. - Key offerings
- Exhibit 155: Bruker Corp. - Segment focus

12.11 F. Hoffmann La Roche Ltd.
- Exhibit 156: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 157: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 158: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 159: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 160: F. Hoffmann La Roche Ltd. - Segment focus

12.12 Gilead Sciences Inc.
- Exhibit 161: Gilead Sciences Inc. - Overview
- Exhibit 162: Gilead Sciences Inc. - Product / Service
- Exhibit 163: Gilead Sciences Inc. - Key news
- Exhibit 164: Gilead Sciences Inc. - Key offerings

12.13 Merck KGaA
- Exhibit 165: Merck KGaA - Overview
- Exhibit 166: Merck KGaA - Business segments
- Exhibit 167: Merck KGaA - Key news
- Exhibit 168: Merck KGaA - Key offerings
- Exhibit 169: Merck KGaA - Segment focus

12.14 Pfizer Inc.
- Exhibit 170: Pfizer Inc. - Overview
- Exhibit 171: Pfizer Inc. - Product / Service
- Exhibit 172: Pfizer Inc. - Key news
- Exhibit 173: Pfizer Inc. - Key offerings

12.15 Regeneron Pharmaceuticals Inc.
- Exhibit 174: Regeneron Pharmaceuticals Inc. - Overview
- Exhibit 175: Regeneron Pharmaceuticals Inc. - Product / Service
- Exhibit 176: Regeneron Pharmaceuticals Inc. - Key offerings

12.16 STEMCELL Technologies Inc.
- Exhibit 177: STEMCELL Technologies Inc. - Overview
- Exhibit 178: STEMCELL Technologies Inc. - Product / Service
- Exhibit 179: STEMCELL Technologies Inc. - Key offerings

12.17 Teva Pharmaceutical Industries Ltd.
- Exhibit 180: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 181: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 182: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 183: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 184: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 185: Inclusions checklist
- Exhibit 186: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 187: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 188: Research methodology
- Exhibit 189: Validation techniques employed for market sizing
- Exhibit 190: Information sources

13.5 List of abbreviations
- Exhibit 191: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

red biotechnology market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis